PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin (Q45253881)
Jump to navigation
Jump to search
scientific article published on 13 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin |
scientific article published on 13 August 2013 |
Statements
1 reference
PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin (English)
1 reference
1 reference
1 reference
Gemma M Ryan
1 reference
David J Owen
1 reference
Christopher J H Porter
1 reference
13 August 2013
1 reference
1 reference
172
1 reference
1
1 reference
128-136
1 reference
Identifiers
1 reference
1 reference